E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
about
Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancerE7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasionNonamplified FGFR1 is a growth driver in malignant pleural mesotheliomaPharmacodynamic change in plasma angiogenic proteins: a dose-escalation phase 1 study of the multi-kinase inhibitor lenvatinib.E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts.Lenvatinib and Palbociclib.Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic targetEffects of tyrosine kinase inhibitor E7080 and eNOS inhibitor L-NIO on colorectal cancer alone and in combinationAnti-angiogenic therapies for malignant pleural mesothelioma.Targeted therapy with kinase inhibitors in aggressive endocrine tumors.Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.Antitumor effect of novel anti-podoplanin antibody NZ-12 against malignant pleural mesothelioma in an orthotopic xenograft model.Proteolytic inactivation of anti-angiogenic vasohibin-1 by cancer cells.Lenvatinib: a new option for the treatment of advanced iodine refractory differentiated thyroid cancer?SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model.The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.Malignant pleural effusion: further translational research is crucial.Fibrocytes: A Novel Stromal Cells to Regulate Resistance to Anti-Angiogenic Therapy and Cancer Progression.Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor.Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas.
P2860
Q28072655-756AEDA9-5ADA-47B6-A3CF-8B3A811941E3Q33968953-310F25EF-D16E-4A84-A479-D6B2450F337AQ34364821-72CFA618-57C5-40F2-B799-C3B10B61A217Q34468729-1184A5B9-F20A-4F8F-A345-ED9CAEBD6B93Q34558883-EA1CC420-128D-4994-8BC1-D44FB50C6B7DQ36109982-D7D73C49-7222-4BA1-B3C8-9C4A1E22A86FQ36159154-17F1A5D5-8D8D-4B55-BFD5-3489A8F7F301Q36392523-1DDE11AF-321E-43CD-8222-2A6687F7C257Q37207654-4AFE0F2F-CB49-429B-A17A-0F0C64D8C0E9Q37309453-391DCAEE-A8D5-4725-9F1F-9E0A1AD33DF0Q38004067-89B84479-0877-4CEE-BFE8-CDF5FAA029D7Q38107011-1C81C0E8-CEF6-48A7-A22D-F8C341109C0EQ38672944-1B0CA179-DEEE-4DFF-AC84-F96DFD20DECFQ38764836-CCFB7DA0-77E2-46E7-A378-589BFAD44900Q38771638-D7D4C241-54A0-4877-8B17-D39A380439A0Q38995525-24FB513B-5D0E-492E-A158-47072A562703Q39350876-8FEED80B-73D7-4916-AACC-2F4C18D0BED7Q39631400-D8297A73-2E5C-41DA-A86D-8A14F5789DCEQ43195730-6EFDE4EA-1FFF-434A-88BF-C1C582172799Q47668446-1F5B0E6F-AD75-40B6-9372-9A17E1293480Q49996923-12637E96-FE46-4A6F-A76C-199305CAF83FQ53520555-1E6EF58E-9E23-443E-B94A-116AED2E4C88Q54311105-59221D21-70C5-4AB9-B796-EDB35B60C228
P2860
E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@en
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@nl
type
label
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@en
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@nl
prefLabel
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@en
E7080, a multi-tyrosine kinase ...... cytokine production profiles.
@nl
P2093
P1476
E7080, a multi-tyrosine kinase ...... c cytokine production profiles
@en
P2093
Hirokazu Ogino
Hisanori Uehara
Hisatsugu Goto
Kenji Ikuta
Masaki Hanibuchi
Saburo Sone
Seiji Yano
Soji Kakiuchi
Toshimitsu Uenaka
P304
P356
10.1158/1078-0432.CCR-09-1980
P407
P577
2009-11-24T00:00:00Z